- Home
- PRAX vs MNRO Comparison
PRAX vs MNRO Comparison
Compare PRAX & MNRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- MNRO
- Stock Information
- Founded
- PRAX 2015
- MNRO 1957
- Country
- PRAX United States
- MNRO United States
- Employees
- PRAX N/A
- MNRO N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- MNRO Automotive Aftermarket
- Sector
- PRAX Health Care
- MNRO Consumer Discretionary
- Exchange
- PRAX Nasdaq
- MNRO Nasdaq
- Market Cap
- PRAX 599.7M
- MNRO 658.9M
- IPO Year
- PRAX 2020
- MNRO 1991
- Fundamental
- Price
- PRAX $38.35
- MNRO $12.22
- Analyst Decision
- PRAX Strong Buy
- MNRO Buy
- Analyst Count
- PRAX 10
- MNRO 4
- Target Price
- PRAX $116.50
- MNRO $20.75
- AVG Volume (30 Days)
- PRAX 430.8K
- MNRO 718.7K
- Earning Date
- PRAX 05-02-2025
- MNRO 05-22-2025
- Dividend Yield
- PRAX N/A
- MNRO 9.16%
- EPS Growth
- PRAX N/A
- MNRO N/A
- EPS
- PRAX N/A
- MNRO 0.62
- Revenue
- PRAX $8,122,000.00
- MNRO $1,210,419,000.00
- Revenue This Year
- PRAX N/A
- MNRO N/A
- Revenue Next Year
- PRAX $789.73
- MNRO $2.89
- P/E Ratio
- PRAX N/A
- MNRO $19.81
- Revenue Growth
- PRAX 270.02
- MNRO N/A
- 52 Week Low
- PRAX $26.70
- MNRO $13.50
- 52 Week High
- PRAX $91.83
- MNRO $31.49
- Technical
- Relative Strength Index (RSI)
- PRAX 53.31
- MNRO 26.08
- Support Level
- PRAX $34.89
- MNRO $13.53
- Resistance Level
- PRAX $40.89
- MNRO $14.40
- Average True Range (ATR)
- PRAX 2.30
- MNRO 0.53
- MACD
- PRAX 0.70
- MNRO -0.10
- Stochastic Oscillator
- PRAX 57.95
- MNRO 0.85
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About MNRO Monro Inc.
Monro Inc is a provider automobile service stations in the United States. Through its network of company-owned service stations, Monro Muffler Brake offers maintenance, repair, tire, and fleet management services for automobiles focused largely on undercar services such as brake, steering, exhaust, drivetrain, and suspension systems. Next to service stores, the company also offers tire stores specialised in tire replacement and service.